Drug interactions between zafirlukast and zileuton
Interactions between your drugs
There were no interactions found in our database between zafirlukast and zileuton - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Zafirlukast is in the drug class leukotriene modifiers.
- Zafirlukast is used to treat Asthma, Maintenance.
- Zileuton is a member of the drug class leukotriene modifiers.
- Zileuton is used to treat Asthma, Maintenance.
Drug and food interactions
Applies to: zafirlukast
Zafirlukast should be taken on an empty stomach 1 hour before or 2 hours after a meal unless otherwise directed by your doctor. You may experience reduced absorption of zafirlukast in the presence of food. This will make it easier for your body to absorb the medication.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'leukotriene modifiers' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'leukotriene modifiers' category:
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.